Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting Diseases
about
Phage-Phagocyte Interactions and Their Implications for Phage Application as Therapeutics.Inducible Prophage Mutant of Escherichia coli Can Lyse New Host and the Key Sites of Receptor Recognition Identification.Means to Facilitate the Overcoming of Gastric Juice Barrier by a Therapeutic Staphylococcal Bacteriophage A5/80.Transcriptomic and Metabolomics Profiling of Phage-Host Interactions between Phage PaP1 and Pseudomonas aeruginosa.Bacteriophages in the gastrointestinal tract and their implicationsPhages and immunomodulation.Phages in the Human Body.Phage therapy for the treatment of human intestinal bacterial infections: soon to be a reality?Modulating the Global Response Regulator, LuxO of V. cholerae Quorum Sensing System Using a Pyrazine Dicarboxylic Acid Derivative (PDCApy): An Antivirulence ApproachEfficacy and Safety of a Bovine-Associated Staphylococcus aureus Phage Cocktail in a Murine Model of Mastitis.Therapeutic potential of phages in autoimmune liver diseases.Phages of life - the path to pharma.Phage therapy in allergic disorders?Compassionate Use of Bacteriophage Therapy for Foot Ulcer Treatment as an Effective Step for Moving Toward Clinical Trials.Can phage therapy solve the problem of recalcitrant chronic rhinosinusitis?Bacteriophages targeting intestinal epithelial cells: a potential novel form of immunotherapy.Silk Route to the Acceptance and Re-Implementation of Bacteriophage Therapy-Part II.Perspectives of Phage-Eukaryotic Cell Interactions to Control Epstein-Barr Virus Infections."Phage Transplantation in Allotransplantation": Possible Treatment in Graft-Versus-Host Disease?Phage Therapy: Beyond Antibacterial Action.The Human Gut Microbiome - A Potential Controller of Wellness and DiseaseResistance Development to Bacteriophages Occurring during Bacteriophage Therapy
P2860
Q33850107-744952DC-A29F-464A-A5D8-3C56BC512B5AQ37617370-0EE563C2-48DC-4629-AA25-747EA92C53A4Q37716726-A3201C52-BE76-4F93-A0CC-21BCDD549CFCQ37735224-98524B81-79A7-4CB3-9B9A-DAB4502B6F1CQ38622847-8A29A5A8-81B0-4955-AA6F-F2AB464ACF46Q38691927-A8FFDF1E-4782-4274-8AEE-57CC64D005B8Q39249579-9B820D48-775B-4209-B3BD-18EACBF23306Q40173306-53C7AF6A-868F-4074-B22C-4236001DA220Q42655611-0E1433CA-77F6-43FA-873C-8320A97725E4Q47124679-56DE1F2A-DA82-44B0-8942-4F4BEE0CE6F3Q47269751-4FD09892-545F-4A37-BD2E-E6DE72B3A5DBQ47269772-69B9107B-7C29-4C66-AED4-3E9ABB21A7C5Q47550004-A461F9DC-BEBF-4EB2-8CB8-B6E1C147A8B1Q47585585-0E047E2B-199A-452E-A0E6-9783BF5C0E10Q47899476-C6908E94-807C-4A9D-81BA-D5520885D62AQ49507986-7717CDCF-4CC7-44F3-880F-7830F639433FQ52431831-D0C543F0-749E-40E5-82DE-203004A4A38DQ53694309-217DA796-4461-41DB-9694-431BB93DF0F3Q54961695-3ED51FBD-982B-49D4-B7D0-E8AB839FF932Q55299223-C350C5B5-B7F5-4930-90C7-F9A3E38297B7Q57169434-A806CB31-85CF-4763-B4C4-540B12373587Q57940652-7DF19B0C-C4F8-4B5B-8B52-C6914EACC31A
P2860
Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting Diseases
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Phage Therapy: Combating Infec ...... ications to Targeting Diseases
@ast
Phage Therapy: Combating Infec ...... ications to Targeting Diseases
@en
Phage Therapy: Combating Infec ...... ications to Targeting Diseases
@nl
type
label
Phage Therapy: Combating Infec ...... ications to Targeting Diseases
@ast
Phage Therapy: Combating Infec ...... ications to Targeting Diseases
@en
Phage Therapy: Combating Infec ...... ications to Targeting Diseases
@nl
prefLabel
Phage Therapy: Combating Infec ...... ications to Targeting Diseases
@ast
Phage Therapy: Combating Infec ...... ications to Targeting Diseases
@en
Phage Therapy: Combating Infec ...... ications to Targeting Diseases
@nl
P2093
P2860
P3181
P356
P1476
Phage Therapy: Combating Infec ...... ications to Targeting Diseases
@en
P2093
Andrzej Górski
Jan Borysowski
Joanna Majewska
Krystyna Dąbrowska
Paweł Rogóż
Ryszard Międzybrodzki
Sławomir Letkiewicz
Wojciech Fortuna
P2860
P3181
P356
10.3389/FMICB.2016.01515
P407
P577
2016-09-26T00:00:00Z